KFS
AKCA

Kelly Financial Services’s Akcea Therapeutics Inc AKCA Stock Holding History

Kelly Financial Services’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-650
Closed -$11.8K – 624
2020
Q3 		$11.8K Hold
650
– – 0.01% 235
2020
Q2 		$8.9K Hold
650
– – 0.01% 261
2020
Q1 		$9.29K Hold
650
– – 0.01% 218
2019
Q4 		$11K Hold
650
– – 0.01% 225
2019
Q3 		$10K Hold
650
– – 0.01% 228
2019
Q2 		$15.2K Buy
+650
New +$16.1K 0.01% 178

Kelly Financial Services's AKCA Position: Q4 2020 in Review

Kelly Financial Services sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 650 shares — an estimated $11.8K sold.

Kelly Financial Services first reported a position in AKCA in Q2 2019 and held it in 6 quarters. The position peaked at $15.2K in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Kelly Financial Services reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Kelly Financial Services sold 650 Akcea Therapeutics Inc shares in Q4 2020, an estimated $11.8K.
  • Kelly Financial Services first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 6 quarters.
  • Kelly Financial Services's Akcea Therapeutics Inc position peaked at $15.2K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Kelly Financial Services's 13F filing for Q4 2020, filed 17 Jul 2024.